|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - VERTEX PHARMACEUTICALS INC (VRTX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-02-19 Sale |
2019-02-21 4:27 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
2,812 | $187 | $525,747 | 18,903 (Indirect Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
5,624 | $187 | $1,051,585 | 36,003 (Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
20,997 | $187 | $3,926,113 | 110,095 (Indirect Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
1,488 | $186.9 | $278,163 | 14,038 (Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
5,624 | $187 | $1,051,716 | 32,604 (Direct) |
View |
| 2019-02-12 Sale |
2019-02-13 4:40 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
35,095 | $180.1 | $6,319,216 | 64,692 (Indirect Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:39 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
111,431 | $180.2 | $20,083,803 | 223,916 (Indirect Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:37 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
33,073 | $180.2 | $5,959,969 | 61,280 (Indirect Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:36 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
32,956 | $180.2 | $5,939,188 | 60,050 (Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:33 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
12,136 | $180.2 | $2,187,190 | 48,869 (Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:27 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
4,215 | $180.2 | $759,367 | 23,386 (Indirect Direct) |
View |
| 2019-02-07 Sale |
2019-02-07 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
1,289 | $193 | $248,777 | 13,938 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
12,722 | $186.9 | $2,377,296 | 48,817 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:50 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
18,309 | $186.2 | $3,409,083 | 54,711 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:49 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
4,247 | $187 | $794,273 | 16,896 (Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:47 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
32,250 | $186.3 | $6,009,682 | 155,815 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:46 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,126 | $189.2 | $780,598 | 41,443 (Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:45 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,330 | $189.2 | $440,813 | 38,489 (Direct) |
View |
| 2019-02-01 Sale |
2019-02-04 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
3,450 | $190.9 | $658,674 | 36,159 (Direct) |
View |
| 2019-01-22 Sale |
2019-01-24 4:47 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
3,668 | $195 | $715,260 | 43,277 (Direct) |
View |
| 2019-01-22 Sale |
2019-01-24 4:46 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,125 | $193.5 | $411,145 | 48,877 (Indirect Direct) |
View |
| 2019-01-22 Sale |
2019-01-24 4:45 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,125 | $193.5 | $411,145 | 41,238 (Direct) |
View |
| 2019-01-18 Sale |
2019-01-22 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $194.6 | $238,020 | 40,336 (Direct) |
View |
| 2019-01-17 Sale |
2019-01-18 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
3,007 | $190.6 | $573,182 | 17,376 (Indirect Direct) |
View |
| 2019-01-14 Sale |
2019-01-15 4:03 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,125 | $186.7 | $396,759 | 41,734 (Direct) |
View |
| 2019-01-04 Sale |
2019-01-07 4:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
4,250 | $165.9 | $705,075 | 43,859 (Direct) |
View |
| 2018-12-26 Purchase |
2018-12-28 4:34 pm |
CRISPR Therapeutics AG | CRSP | Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner |
40,198 | $24.93 | $1,002,194 | 5,380,940 (Direct) |
View |
| 2018-12-21 Purchase |
2018-12-26 4:35 pm |
CRISPR Therapeutics AG | CRSP | Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner |
90,742 | $24.08 | $2,184,960 | 5,340,742 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-04 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
809 | $186.5 | $150,895 | 16,896 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-02-21 Option Award |
2019-02-22 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | CARNEY LLOYD Director |
2,161 | $0 | 2,161 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
17,298 | $0 | 75,260 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
10,126 | $0 | 75,260 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
9,799 | $0 | 75,260 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:51 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
25,026 | $187.5 | 75,260 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
4,220 | $0 | 24,786 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
2,917 | $0 | 24,786 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
5,000 | $0 | 24,786 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:50 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
7,449 | $187.5 | 24,786 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
53,816 | $0 | 238,623 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
31,498 | $0 | 238,623 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
28,444 | $0 | 238,623 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:48 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
72,647 | $187.5 | 238,623 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
8,438 | $0 | 52,763 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
8,166 | $0 | 52,763 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:43 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
20,855 | $187.5 | 52,763 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:39 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
3,516 | $0 | 25,026 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:39 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
9,799 | $0 | 25,026 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:39 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
25,026 | $187.5 | 25,026 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
14,416 | $0 | 70,133 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
8,438 | $0 | 70,133 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
8,166 | $0 | 70,133 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:37 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
20,855 | $187.5 | 70,133 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
17,298 | $0 | 71,937 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
8,438 | $0 | 71,937 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
9,799 | $0 | 71,937 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:33 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
25,026 | $187.5 | 71,937 (Direct) |
View |
| 2019-02-07 Exercise |
2019-02-07 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
1,289 | $91.05 | 13,938 (Direct) |
View |
| 2019-02-07 Exercise |
2019-02-07 4:04 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
1,289 | $91.05 | 13,938 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
1,942 | $86.52 | 48,817 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
2,155 | $91.05 | 48,817 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:51 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
1,942 | $86.52 | 48,817 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:51 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
2,155 | $91.05 | 48,817 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
4,250 | $109.4 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,155 | $91.05 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
1,554 | $86.52 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A 2025-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
4,250 | $109.1 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,155 | $91.05 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
1,554 | $86.52 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
809 | $86.52 | 16,896 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:49 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
809 | $86.52 | 16,896 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,796 | $91.05 | 41,443 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $86.52 | 41,443 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:46 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,796 | $91.05 | 41,443 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:46 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $86.52 | 41,443 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:45 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,330 | $86.52 | 38,489 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:45 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,330 | $86.52 | 38,489 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 4:47 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
3,668 | $155.6 | 43,277 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 4:47 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
3,668 | $155.6 | 43,277 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,125 | $131.9 | 48,877 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 4:46 pm |
N/A 2025-07-20 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,125 | $131.9 | 48,877 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 4:45 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,125 | $131.9 | 41,238 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 4:45 pm |
N/A 2025-07-20 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,125 | $131.9 | 41,238 (Direct) |
View |
| 2019-01-18 Exercise |
2019-01-22 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $155.7 | 40,336 (Direct) |
View |
| 2019-01-18 Exercise |
2019-01-22 4:07 pm |
N/A 2028-02-25 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,223 | $155.7 | 40,336 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-18 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
1,289 | $91.05 | 17,376 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-18 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
859 | $90.29 | 17,376 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-18 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
859 | $90.29 | 17,376 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-18 4:18 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
1,289 | $91.05 | 17,376 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-18 4:18 pm |
N/A 2026-07-11 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
859 | $90.29 | 17,376 (Direct) |
View |
| 2019-01-17 Exercise |
2019-01-18 4:18 pm |
N/A 2026-07-11 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
859 | $90.29 | 17,376 (Direct) |
View |
| 2019-01-15 Option Award |
2019-01-16 4:52 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
243 | $184.9 | 9,330 (Direct) |
View |
| 2019-01-14 Exercise |
2019-01-15 4:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,125 | $90.29 | 41,734 (Direct) |
View |
| 2019-01-14 Exercise |
2019-01-15 4:03 pm |
N/A 2026-07-11 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,125 | $90.29 | 41,734 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-07 4:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
4,250 | $122.4 | 43,859 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-07 4:02 pm |
N/A 2026-01-03 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
4,250 | $122.4 | 43,859 (Direct) |
View |
| 2018-12-28 Gift |
2019-01-02 4:58 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
10,000 | $0 | 13,011 (Direct) |
View |
| 2018-12-06 Exercise |
2018-12-07 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
10,000 | $34.24 | 23,011 (Direct) |
View |
| 2018-12-06 Exercise |
2018-12-07 4:06 pm |
N/A 2020-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
10,000 | $34.24 | 23,011 (Direct) |
View |
| 2018-12-03 Exercise |
2018-12-04 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
809 | $86.52 | 16,896 (Direct) |
View |
| 2018-12-03 Exercise |
2018-12-04 4:04 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
809 | $86.52 | 16,896 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Fri, 22 Mar 2019 20:24:14 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |